Silva Debora Cristina Pereira da, Carneiro Felipe Demani, Almeida Kelly Costa de, Fernandes-Santos Caroline
Programa de Pós-graduação em Ciências Cardiovasculares da Universidade Federal Fluminense (UFF), Niterói, RJ - Brazil.
Universidade Federal Fluminense (UFF), Nova Friburgo, RJ - Brazil.
Arq Bras Cardiol. 2018 Nov;111(5):738-746. doi: 10.5935/abc.20180215.
MiRNA (or microRNA) is a subclass of non-coding RNAs that is responsible for post-transcriptional gene regulation. It has approximately 22 nucleotides and regulates gene expression in plants and animals at the post-transcriptional level, by the cleavage of a target mRNA or by suppression of its translation. Although many of the processes and mechanisms have not yet been fully elucidated, there is a strong association between miRNA expression and several diseases. It is known that miRNAs are expressed in the cardiovascular system, but their role in cardiovascular diseases (CVDs) has not been clearly established. In this non-systematic review of the literature, we first present the definition of miRNAs and their action at the cellular level. Afterward, we discuss the role of miRNAs as circulating biomarkers of CVDs, and then their role in cardiac remodeling and atherosclerosis. Despite the complexity and challenges, it is crucial to identify deregulated miRNAs in CVDs, as it allows a better understanding of underlying cellular and molecular mechanisms and helps in the development of more accurate diagnostic and prognostic circulating biomarkers, and new therapeutic strategies for different stages of CVDs.
微小RNA(或miRNA)是一类非编码RNA,负责转录后基因调控。它大约有22个核苷酸,通过切割靶mRNA或抑制其翻译,在转录后水平调控植物和动物的基因表达。尽管许多过程和机制尚未完全阐明,但miRNA表达与多种疾病之间存在密切关联。已知miRNA在心血管系统中表达,但其在心血管疾病(CVD)中的作用尚未明确确立。在这篇非系统性文献综述中,我们首先介绍miRNA的定义及其在细胞水平的作用。之后,我们讨论miRNA作为CVD循环生物标志物的作用,然后是它们在心脏重塑和动脉粥样硬化中的作用。尽管存在复杂性和挑战,但识别CVD中失调的miRNA至关重要,因为这有助于更好地理解潜在的细胞和分子机制,并有助于开发更准确的诊断和预后循环生物标志物,以及针对CVD不同阶段的新治疗策略。